Memorial Antalya Hospital
Stem cell ovarian rejuvenation in Turkey typically costs from AUD $5,714 to AUD $9,999. Final figures depend on the specific regenerative protocol used, such as autologous cells or donor umbilical cord mesenchymal stem cells. Patients save around 42% by travelling to Turkey from Australia, where this procedure costs AUD $13,570 on average. Standard packages often include initial consultations, hormone blood tests, local anaesthetic, and ultrasound-guided injections.
Bookimed Expert Insight: Choosing JCI-accredited facilities provides Australian patients with high standards of clinical governance. Memorial Antalya Hospital maintains this international accreditation while serving a high volume of international cases. Many experienced specialists, like Professor Meryem Eken at Medical Park Göztepe, bridge the gap between academic research and clinical practice. Coordination through such established centres often includes VIP airport transfers and multi-language support as part of the total cost.
| Turkey | Thailand | ||
| Stem Cell Ovarian Rejuvenation | from AUD $5,714 | from AUD $9,999 | from AUD $4,999 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem Cell Ovarian Rejuvenation upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem Cell Ovarian Rejuvenation and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem Cell Ovarian Rejuvenation journey.
Dr. Tayfun Kutlu is a reproductive endocrinologist at Anadolu Medical Center in Istanbul. He specializes in IVF and microwave endometrial ablation. He performs ovarian and vaginal rejuvenation using Platelet-Rich Plasma (PRP) therapy. Dr. Kutlu holds a certificate in Assisted Reproduction Treatment Methods. He also completed training in laparoscopic surgery.
Op. Dr. Semih Özçınar is a plastic, reconstructive, and aesthetic surgeon. He earned his M.D. from Ankara University and completed his plastic surgery residency at İnönü University. He is a member of the International Society of Aesthetic Plastic Surgery (ISAPS).
His scientific work includes an oral presentation at the 2022 National Congress of the Turkish Society of Plastic, Reconstructive and Aesthetic Surgery titled "Retrospective Analysis of Regional, Free, and Local Flaps in Head and Neck Reconstruction." He also wrote a thesis on the effect of septocolumellar flap use on nasal tip projection in rhinoplasty.
He has completed training in ISAPS Live Surgery Rhinoplasty, the ISAPS World Congress 2022 in Istanbul, Bosphorus Breast Live Surgery, the 9th Rhinoplasty & Facial Aesthetics fresh cadaver course, BTS International Aesthetic in Sweden, and FABCAST meetings. His focus areas are facial aesthetics, breast surgery, body contouring, and reconstruction.
Dr. Hediye Dagdeviren is an Associate Professor of Obstetrics and Gynecology at VM Medical Park Florya. She specializes in IVF and reproductive difficulties. She holds an official certification in Assisted Reproductive Therapy. Dr. Dagdeviren practices at a JCI-accredited university hospital in Istanbul.
Dr. Meryem Eken is a professor and head of the IVF Unit at Medical Park Göztepe Hospital. She focuses on infertility, including natural-cycle IVF and intrauterine insemination. She is a winner of the Turkish Society of Gynecology and Obstetrics First Prize. Dr. Eken previously led the IVF Unit at Hisar Intercontinental Hospital.
Stem cell ovarian rejuvenation in Turkey carries risks including localised pelvic pain and internal bleeding. There is also a risk of infection from transvaginal injections. Patients may experience unpredictable results in hormone levels. Safety is highest at JCI-accredited facilities where specialists like Dr Meryem Eken use standardised cell isolation protocols.
Bookimed Expert Insight: Quality varies significantly across Turkey’s 390 clinics. Leading centres like Memorial Antalya Hospital maintain JCI accreditation for rigorous laboratory infection control. This is vital for biological therapies where cell purity impacts both safety and success rates.
Patient Consensus: Turkish clinics provide detailed documentation. However, patients suggest organising local follow-up care before departing Australia. Most find that managing expectations about hormone improvements helps them navigate the recovery period.
Stem cell ovarian rejuvenation in Turkey achieves biological reactivation in 67% to 70% of cases. Success varies by outcome metric. Clinical pregnancy rates typically range between 15% and 35%. Results depend on patient age, hormone levels, and the specific regenerative protocol used.
Bookimed Expert Insight: Turkish centres often combine stem cell therapy with Platelet-Rich Plasma (PRP). Specialists like Dr. Meryem Eken at Medical Park Göztepe Hospital use these integrated protocols. This approach targets both tissue repair and local growth factor concentration for better results.
Patient Consensus: Success in Turkey is often measured by improved AMH levels. It is rarely measured by guaranteed live births. Patients recommend confirming if a clinic's figures refer to laboratory changes or confirmed pregnancies.
Ideal candidates for stem cell ovarian rejuvenation in Turkey are women under 45–50. It is for those with a diminished ovarian reserve or premature ovarian insufficiency (POI).
This regenerative treatment suits patients seeking to use their own genetic material. Unlike other regions, Turkey strictly prohibits egg, sperm, or embryo donation.
Bookimed Expert Insight: Bookimed data shows Turkey is a leader for this procedure. It has 390 clinics serving nearly 2,000 requests. Surgeons like Dr. Tayfun Kutlu at Anadolu Medical Center bring 24+ years of experience. This high volume results in specialised protocols compared to smaller markets.
Patient Consensus: Patients with early ovarian ageing focus on improving hormone markers and egg quality before IVF. Realistic expectations are vital as results vary. Verifying ovarian function via AMH tests beforehand is essential.
Biological rejuvenation in Turkey triggers ovarian repair through paracrine signalling rather than creating new eggs. Injected mesenchymal stem cells release growth factors and exosomes. These restore the ovarian microenvironment and stimulate dormant follicles. They also improve blood flow in JCI-accredited facilities like Memorial Antalya Hospital.
Bookimed Expert Insight: Turkish specialists like Dr Tayfun Kutlu at Anadolu Medical Center often combine regenerative techniques with reproductive endocrinology experience. Data reveals that clinics often pair stem cell therapy with follow-up monitoring of AMH and FSH levels. This provides patients with a comprehensive metabolic assessment alongside the cellular injections.
Patient Consensus: Patients in Turkey describe the process as a way to boost blood flow and calm inflammation. Most say it works best when some natural ovarian activity remains before starting treatment.
Patients typically see biological results 3 to 6 months after stem cell ovarian rejuvenation in Turkey. Early hormonal shifts can occur within 1 to 3 months. Peak biological impacts on egg quality and follicular activity generally appear around the 6-month mark.
Bookimed Expert Insight: Turkish records indicate that 20+ year veterans like Dr Tayfun Kutlu advise waiting 3 months before starting IVF. This allows cellular rejuvenation to improve hormone profiles. A single treatment typically plateaus after 6 months. Timing your follow-up cycles is critical for success.
Patient Consensus: Expect a gradual response over several menstrual cycles rather than instant changes in Turkey. Most rely on objective scans and blood tests back in Australia to confirm results. Use these tools to track follicle activity and hormone levels rather than daily symptoms.